PortfoliosLab logoPortfoliosLab logo
KFRC vs. MRK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KFRC vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kforce Inc. (KFRC) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KFRC achieves a 52.32% return, which is significantly higher than MRK's 9.78% return. Over the past 10 years, KFRC has outperformed MRK with an annualized return of 11.79%, while MRK has yielded a comparatively lower 11.18% annualized return.


KFRC

1D
-3.11%
1M
7.63%
YTD
52.32%
6M
58.65%
1Y
18.12%
3Y*
-5.02%
5Y*
-3.22%
10Y*
11.79%

MRK

1D
-0.82%
1M
1.41%
YTD
9.78%
6M
13.95%
1Y
54.09%
3Y*
3.77%
5Y*
12.62%
10Y*
11.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KFRC vs. MRK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
KFRC
Kforce Inc.
52.32%-43.07%-14.03%26.14%-25.69%81.56%8.49%31.03%24.68%11.85%
MRK
Merck & Co., Inc.
9.78%9.79%-6.26%1.01%49.42%1.75%-7.20%22.27%39.95%-1.49%

Correlation

The correlation between KFRC and MRK is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Aug 16, 1995

0.19

Fundamentals

Market Cap

KFRC:

$798.28M

MRK:

$283.54B

EPS

KFRC:

$1.95

MRK:

$3.58

PE Ratio

KFRC:

23.76

MRK:

32.00

PS Ratio

KFRC:

0.62

MRK:

4.36

PB Ratio

KFRC:

6.80

MRK:

6.18

Total Revenue (TTM)

KFRC:

$1.33B

MRK:

$65.59B

Gross Profit (TTM)

KFRC:

$361.86M

MRK:

$49.79B

EBITDA (TTM)

KFRC:

$53.65M

MRK:

$22.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KFRC vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KFRC
KFRC Risk / Return Rank: 5252
Overall Rank
KFRC Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
KFRC Sortino Ratio Rank: 5555
Sortino Ratio Rank
KFRC Omega Ratio Rank: 5555
Omega Ratio Rank
KFRC Calmar Ratio Rank: 4949
Calmar Ratio Rank
KFRC Martin Ratio Rank: 4747
Martin Ratio Rank

MRK
MRK Risk / Return Rank: 8787
Overall Rank
MRK Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 8787
Sortino Ratio Rank
MRK Omega Ratio Rank: 8484
Omega Ratio Rank
MRK Calmar Ratio Rank: 9090
Calmar Ratio Rank
MRK Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KFRC vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kforce Inc. (KFRC) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


KFRCMRKDifference

Sharpe ratio

Return per unit of total volatility

0.27

2.02

-1.75

Sortino ratio

Return per unit of downside risk

1.09

2.94

-1.85

Omega ratio

Gain probability vs. loss probability

1.14

1.35

-0.21

Calmar ratio

Return relative to maximum drawdown

0.39

4.78

-4.40

Martin ratio

Return relative to average drawdown

0.61

12.00

-11.39

KFRC vs. MRK - Sharpe Ratio Comparison

The current KFRC Sharpe Ratio is 0.27, which is lower than the MRK Sharpe Ratio of 2.02. The chart below compares the historical Sharpe Ratios of KFRC and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


KFRCMRKDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.27

2.02

-1.75

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.08

0.54

-0.61

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.30

0.49

-0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

0.17

0.48

-0.31

Drawdowns

KFRC vs. MRK - Drawdown Comparison

The maximum KFRC drawdown since its inception was -94.60%, which is greater than MRK's maximum drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for KFRC and MRK.


Loading charts...

Drawdown Indicators


KFRCMRKDifference

Max Drawdown

Largest peak-to-trough decline

-94.60%

-68.61%

-25.99%

Max Drawdown (1Y)

Largest decline over 1 year

-47.03%

-11.37%

-35.66%

Max Drawdown (3Y)

Largest decline over 3 years

-64.72%

-43.44%

-21.28%

Max Drawdown (5Y)

Largest decline over 5 years

-66.41%

-43.44%

-22.97%

Max Drawdown (10Y)

Largest decline over 10 years

-66.41%

-43.44%

-22.97%

Current Drawdown

Current decline from peak

-34.68%

-8.50%

-26.18%

Average Drawdown

Average peak-to-trough decline

-42.73%

-18.84%

-23.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.77%

4.52%

+25.25%

Volatility

KFRC vs. MRK - Volatility Comparison

Kforce Inc. (KFRC) has a higher volatility of 12.00% compared to Merck & Co., Inc. (MRK) at 8.21%. This indicates that KFRC's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KFRCMRKDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.00%

8.21%

+3.79%

Volatility (6M)

Calculated over the trailing 6-month period

47.26%

17.62%

+29.64%

Volatility (1Y)

Calculated over the trailing 1-year period

68.12%

26.92%

+41.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

41.55%

23.62%

+17.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.60%

22.91%

+16.69%

Dividends

KFRC vs. MRK - Dividend Comparison

KFRC's dividend yield for the trailing twelve months is around 3.38%, more than MRK's 2.89% yield.


PositionTTM20252024202320222021202020192018201720162015
KFRC
Kforce Inc.
3.38%5.05%2.68%2.13%2.19%1.30%1.90%1.81%1.94%1.90%2.08%1.78%
MRK
Merck & Co., Inc.
2.89%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%

Financials

KFRC vs. MRK - Financials Comparison

This section allows you to compare key financial metrics between Kforce Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
330.36M
16.29B
(KFRC) Total Revenue
(MRK) Total Revenue
Values in USD except per share items

KFRC vs. MRK - Profitability Comparison

The chart below illustrates the profitability comparison between Kforce Inc. and Merck & Co., Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
27.3%
81.9%
Portfolio components
KFRC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kforce Inc. reported a gross profit of 90.07M and revenue of 330.36M. Therefore, the gross margin over that period was 27.3%.

MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.

KFRC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kforce Inc. reported an operating income of 12.01M and revenue of 330.36M, resulting in an operating margin of 3.6%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.

KFRC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kforce Inc. reported a net income of 7.93M and revenue of 330.36M, resulting in a net margin of 2.4%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.


Frequently Asked Questions


KFRC and MRK have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KFRC has higher volatility (12.00%) compared to MRK (8.21%). In terms of maximum drawdown, KFRC dropped -94.60% vs MRK's -68.61%.

MRK currently has the higher Sharpe Ratio (2.02 vs 0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KFRC and MRK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer